Baird Financial Group’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-21,254
| Closed | -$1.09M | – | 1513 |
|
|
2020
Q2 | $1.09M | Buy |
+21,254
| New | +$1.09M | ﹤0.01% | 901 |
|
|
2020
Q1 | – | Sell |
-18,829
| Closed | -$1.12M | – | 1461 |
|
|
2019
Q4 | $1.12M | Buy |
18,829
+305
| +2% | +$18.2K | ﹤0.01% | 933 |
|
|
2019
Q3 | $679K | Buy |
18,524
+849
| +5% | +$31.1K | ﹤0.01% | 1082 |
|
|
2019
Q2 | $823K | Buy |
+17,675
| New | +$823K | ﹤0.01% | 1055 |
|
|
2016
Q2 | – | Sell |
-10,240
| Closed | -$173K | – | 1211 |
|
|
2016
Q1 | $173K | Buy |
+10,240
| New | +$173K | ﹤0.01% | 1167 |
|